Clin2
NCT07291895Possibly a fitNot yet recruiting

High-dose radiation therapy to relieve symptoms from advanced cancer

MetastasesPalliative Radiotherapy

Part of Cancer clinical trials.

This trial tests higher doses of radiation therapy to relieve symptoms from larger tumors that cannot be cured. The goal is to improve symptom control and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
21 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have a solid tumor cancer (not a blood cancer).
  • Your cancer is not curable with standard treatment, or you have chosen not to have curative treatment.
  • You have 1 to 3 tumors that are larger than 5 centimeters (about 2 inches) and are causing symptoms, but no more than 2 tumors in the same organ.
  • You are generally able to carry out daily activities (ECOG 0-2).
  • You have had a recent CT or PET scan within the last 8 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06778408Recruiting· Phase 2
Hybrid arc palliative radiation therapy for metastasis

This trial tests a new radiation technique for people with cancer that has spread to bones or soft tissues in the chest, belly, or pelvis. The goal is to safely deliver effective palliative radiation to ease symptoms.

Burlington, Vermont
NCT06794125Recruiting
Higher radiation dose for chest tumors

This trial tests if giving a higher dose of radiation to tumors in the chest (lungs or nearby areas) can better control symptoms or prevent them from getting worse. It is for people who need palliative radiation—treatment aimed at easing discomfort or slowing tumor growth, not curing the cancer.

Kelowna, British Columbia
NCT07856394Recruiting
Adding a special type of radiation to standard palliative radiation

This study tests whether adding a special type of radiation to standard palliative radiation helps reduce symptoms like pain, shortness of breath, or bleeding. It's for people with tumors that can't be removed and are large.

Scottsdale, Arizona
NCT04068649Recruiting· Phase 2
Single high-dose radiation vs standard palliative radiation

This Phase 2 study compares a one-time, high-dose radiation treatment (SBRT) with the usual, shorter-course palliative radiation. The goal is to see which approach better relieves symptoms from metastatic (spread) cancer.

Buffalo, New York
NCT05419518Recruiting· Phase 2
Higher-dose radiation to ease pain from metastatic tumors

This Phase 2 study tests whether a stronger (higher-dose) radiation plan can better reduce pain from tumors that have spread to bone or other areas. It’s meant to help people live more comfortably by targeting painful spots while avoiding certain high-risk situations.

Hamilton, New Jersey
NCT05717166Recruiting· Phase 3
Stereotactic radiation for limited metastases with a main tumor

This trial tests whether a precise type of radiation can control cancer that has spread to a limited number of sites (1–10) while you also have the main tumor. It aims to improve outcomes by treating all visible cancer spots with stereotactic ablative radiotherapy.

Prince George, British Columbia

Hear when a new Metastases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.